Severe congenital dyserythropoietic anaemia type I:: prenatal management, transfusion support and alpha-interferon therapy

被引:41
作者
Parez, N
Dommergues, M
Zupan, V
Chambost, ZH
Fieschi, JB
Delaunay, J
Miélot, F
Cramer, EM
Dommergues, JP
Wickramasinghe, SN
Tchernia, G
机构
[1] Hop Bicetre, Dept Hematol Immunol & Cytogenet, AP HP, Serv Pediat Gen, F-94275 Le Kremlin Bicetre, France
[2] Fac Med Paris Sud, F-94276 Le Kremlin Bicetre, France
[3] Hop Antoine Beclere, AP HP, Clamart, France
[4] Fac Med Paris Sud, Clamart, France
[5] Hop Necker Enfants Malad, AP HP, Paris, France
[6] Fac Med Necker Enfants Malad, Paris, France
[7] Hop Enfants La Timone, Serv Hematol Pediat, Marseille, France
[8] Hop Bicetre, Serv Hematol Immunol & Cytogenet, AP HP, Le Kremlin Bicetre, France
[9] Hop Cochin, INSERM, U474, F-75674 Paris, France
[10] Imperial Coll Sch Med, Dept Haematol, London, England
关键词
congenital dyserythropoietic anaemia; alpha-interferon; infant; prenatal diagnosis; intrauterine transfusion;
D O I
10.1046/j.1365-2141.2000.02168.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a case of congenital dyserythropoietic anaemia, type I, with severe pre- and postnatal manifestations. Exchange transfusions were required for fetal anaemia (3.5 g/dl) at 28 and 30 weeks of gestation. Transfusions were administered at birth (Caesarean section at week 35) and at regular interals thereafter. At 14 months, alpha-interferon therapy was initiated (10(6) units three times a week). This resulted in stabilization of the haemoglobin at or above 11 g/dl and a reduction in the percentage of erythroblasts with ultrastructurally abnormal heterochromatin. After 9 months, the dose of alpha-interferon was decreased to 10(6) units twice a week. No relapse of anaemia was noted during an additional 4 months of follow-up.
引用
收藏
页码:420 / 423
页数:4
相关论文
共 12 条
  • [1] Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy
    Barlow, CF
    Priebe, CJ
    Mulliken, JB
    Barnes, PD
    Mac Donald, D
    Folkman, J
    Ezekowitz, RAB
    [J]. JOURNAL OF PEDIATRICS, 1998, 132 (03) : 527 - 530
  • [2] Genetic heterogeneity of congenital dyserythropoietic anemia type I
    Hodges, VM
    Molloy, GY
    Wickramasinghe, SN
    [J]. BLOOD, 1999, 94 (03) : 1139 - 1140
  • [3] LAVABREBERTRAND T, 1995, BRIT J HAEMATOL, V89, P929
  • [4] ACRAL DYSOSTOSIS DYSERYTHROPOIESIS SYNDROME
    LEMERRER, M
    GIROT, R
    PARENT, P
    CORMIERDAIRE, V
    MAROTEAUX, P
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (05) : 384 - 388
  • [5] Menike D, 1998, BRIT J HAEMATOL, V103, P825
  • [6] Neonatal manifestations of congenital dyserythropoietic anemia type I
    Shalev, H
    Tamary, H
    Shaft, D
    Reznitsky, P
    Zaizov, R
    [J]. JOURNAL OF PEDIATRICS, 1997, 131 (01) : 95 - 97
  • [7] Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3
    Tamary, H
    Shalmon, L
    Shalev, H
    Halil, A
    Dobrushin, D
    Ashkenazi, N
    Zoldan, M
    Resnitzky, P
    Korostishevsky, M
    Bonne-Tamir, B
    Zaizov, R
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) : 1062 - 1069
  • [8] Tamary H, 1996, BLOOD, V87, P1763
  • [9] Reduced interferon-alpha production by Epstein-Barr virus transformed B-lymphoblastoid cell lines and lectin-stimulated lymphocytes in congenital dyserythropoietic anaemia type I
    Wickramasinghe, SN
    Hasan, R
    Smythe, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) : 295 - 298
  • [10] Dyserythropoiesis and congenital dyserythropoietic anaemias
    Wickramasinghe, SN
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) : 785 - 797